非酒精性脂肪性肝病的创新治疗方法:当了解您的患者是关键时
Marta Alonso-Peña1, Maria Del Barrio1, Ana Peleteiro-Vigil1
1Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, 39011 Santander, Spain.
International journal of molecular sciences
|July 14, 2023
概括
非酒精性脂肪性肝病 (NAFLD) 呈现出不同的表型. 基于患者表型的个性化治疗提供了一种有希望的方法,可以在管理这种复杂的肝病时获得更好的结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 是一系列的肝脏疾病,从简单的脂肪性肝炎到非酒精性脂肪性肝炎 (NASH).
- 多种分子途径和触发因素有助于肝硬化,NASH的进展包括炎症和纤维化.
- NAFLD与显著的肝外共患病,如代谢综合征,2型糖尿病,肥胖和心血管疾病有关.
研究的目的:
- 审查NAFLD患者的多样化表型特征.
- 突出NAFLD多因素病因和多种病理生理路径.
- 提出患者表型和个性化治疗作为一种创新的治疗策略.
主要方法:
- 对NAFLD现有的文献进行叙述性审查.
- 对NAFLD表现的表型异质性的分析.
- 讨论不同的分子触发物和病理生理路径.
主要成果:
- 在患者表现和疾病进展方面,NAFLD表现出显著的异质性.
- 不同的触发因素和途径有助于NAFLD的发展和严重程度.
- 由于这种异质性,目前广泛的治疗方法取得了有限的成功.
结论:
- 对NAFLD患者的准确表型确定对于了解疾病机制至关重要.
- 针对特定患者表型量身定制的个性化治疗策略可能会改善治疗结果.
- 为了有效的NAFLD管理,需要转向精准医学.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
115
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
115
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
357
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
357
Ultrasound II: Endoscopic Ultrasound and FibroScan
143
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
143
Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13
Inflammatory Bowel Disease IV: Pharmacological Management
154
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
154
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319


